Exelixis Inc
EXEL
$57.29+0.99%
Delayed · as of Sep 24, 2026, 2:00 PM ET
Mkt cap
$12.69B
EV/Sales
5.26
P/E ratio
N/A
FY2026 Revenue
$2.32B
EPS (TTM)
$3.18
Gross Margin (FY2026)
96.39%
Profit Margin (FY2026)
33.73%
Beta
0.39
Div yield
N/A
Sector
Healthcare
Exelixis Inc (EXEL) is a biotechnology company listed on US.
Latest reported EXEL revenue for 2026-01-02 was $2.32B. Net income was $782.6M. Revenue was up 7.0% from 2025-01-03 to 2026-01-02. EXEL currently screens at market cap $12.69B.
Use this EXEL research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full EXEL income, balance, and cash tables.
Exelixis Inc (EXEL) is a biotechnology company in the Healthcare sector.
Latest cached Exelixis Inc (EXEL) revenue for Jan 2, 2026 was $2.32B. Net income was $782.6M. Statements: https://lician.com/financials/exel
Exelixis Inc (EXEL) market capitalization is $12.69B on the latest cached snapshot.
Exelixis Inc (EXEL) cached previous close $56.73; day range $56.58 – $57.49; volume 622,347. Session quote: https://lician.com/quote/exel
Exelixis Inc (EXEL) latest cached earnings event is "EXEL earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached EXEL filing is 8-K · Sep 11, 2026. Filings: https://lician.com/sec/exel